Organon & Co. (OGN)
NYSE
13.79
+0.05 (+0.36%)
Closed
Oct 7, 2026
Day's Range
13.7213.79
52 wk Range
5.6913.79
Financial Statements - OGN - Organon & Co.
Revenue
6.21B▼ 2.9%
Net Income
187.00M▼ 78.4%Net Margin 3.0%
EBITDA
1.70B▼ 2.1%
Free Cash Flow
384.00M▼ 34.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 6.21B | 6.40B | 6.26B | 6.17B | 6.30B | 6.53B |
| Cost of Goods | 2.90B | 2.68B | 2.51B | 2.29B | 2.38B | 2.11B |
| Gross Profit | 3.31B | 3.71B | 3.74B | 3.88B | 3.92B | 4.41B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 1.22B | 1.48B | 1.32B | 1.70B | 1.91B | 2.84B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -297M | -159M | -127M | -161M | -128M | -95M |
| Pre Tax Income | 425M | 807M | 673M | 1.12B | 1.52B | 2.75B |
| Income Tax | 238M | -57M | -350M | 205M | 178M | 496M |
| Net Income | 187M | 864M | 1.02B | 917M | 1.35B | 2.16B |
| EPS Basic | 0.72 | 3.36 | 4.01 | 3.61 | 5.33 | 8.533152 |
| EPS Diluted | 0.72 | 3.33 | 3.99 | 3.59 | 5.31 | 8.533152 |
| Basic Shares Outstanding | 259.49M | 257.04M | 255.23M | 254.08M | 253.53M | 253.13M |
| Diluted Shares Outstanding | 259.49M | 257.04M | 255.23M | 254.08M | 253.53M | 253.13M |
| Ebit | 929M | 1.32B | 1.20B | 1.54B | 1.78B | 2.75B |
| Ebitda | 1.70B | 1.74B | 1.54B | 1.90B | 2.09B | 2.99B |
| Net Income Continuous Operations | 187M | 864M | 1.02B | 917M | 1.35B | 2.25B |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
